CEFOTAXIME PHARMACOKINETICS AND TREATMENT OF MENINGITIS IN NEONATES

被引:6
作者
JACOBS, RF [1 ]
KEARNS, GL [1 ]
机构
[1] ARKANSAS CHILDRENS HOSP, LITTLE ROCK, AR 72202 USA
关键词
D O I
10.1007/BF01650725
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:338 / 342
页数:5
相关论文
共 36 条
[1]   CEFOTAXIME DIFFUSION INTO CEREBROSPINAL-FLUID OF CHILDREN WITH MENINGITIS [J].
ASMAR, BI ;
THIRUMOORTHI, MC ;
BUCKLEY, JA ;
KOBOS, DM ;
DAJANI, AS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :138-140
[2]   PHARMACOKINETICS OF CEFOTAXIME IN NEONATES [J].
BAIRDLAMBERT, J ;
DOYLE, PE ;
THOMAS, D ;
CVEJIC, M ;
BUCHANAN, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (05) :471-477
[3]   CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS [J].
BALANT, L ;
DAYER, P ;
AUCKENTHALER, R .
CLINICAL PHARMACOKINETICS, 1985, 10 (02) :101-143
[4]   PHARMACOKINETIC PROPERTIES OF THE CEPHALOSPORINS [J].
BERGAN, T .
DRUGS, 1987, 34 :89-104
[5]   PRINCIPLES OF DRUG BIODISPOSITION IN THE NEONATE - A CRITICAL-EVALUATION OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERFACE .1. [J].
BESUNDER, JB ;
REED, MD ;
BLUMER, JL .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :189-216
[6]   CEFOTAXIME LEVELS IN VENTRICULAR CEREBROSPINAL-FLUID, DETERMINED BY BIOASSAY AND BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BRUCKNER, O ;
COLLMANN, H ;
BORNER, K .
CHEMOTHERAPY, 1983, 29 (04) :237-243
[7]   METABOLISM OF CEFOTAXIME IN ANIMALS AND MAN [J].
CHAMBERLAIN, J ;
COOMBES, JD ;
DELL, D ;
FROMSON, JM ;
INGS, RJ ;
MACDONALD, CM ;
MCEWEN, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 :69-78
[8]   PHARMACOKINETICS OF CEFOTAXIME AND DESACETYL-CEFOTAXIME IN NEONATES [J].
CROOKS, J ;
WHITE, LO ;
BURVILLE, LJ ;
SPEIDEL, BD ;
REEVES, DS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 :97-101
[9]  
DELOUVOIS J, 1982, PEDIATR PHARMACOL, V2, P275
[10]   EFFECT OF PRENATAL EXPOSURE TO BETAMETHASONE ON METRONIDAZOLE ELIMINATION IN PREMATURE-INFANTS [J].
DOYLE, PE ;
JAGERROMAN, E ;
BAIRDLAMBERT, J ;
CVEJIC, M ;
BUCHANAN, N .
JOURNAL OF PEDIATRICS, 1982, 101 (04) :647-647